Practice Cases Arrythmias/Stroke/ACS Exam 4

Practice Cases Arrythmias/Stroke/ACS Exam 4

University

62 Qs

quiz-placeholder

Similar activities

CMA 480 - Exam 2 Review - Chapters:4-6

CMA 480 - Exam 2 Review - Chapters:4-6

University

60 Qs

Preliminary Examination in NSTP2

Preliminary Examination in NSTP2

University

60 Qs

VT7_Telemarketing

VT7_Telemarketing

University - Professional Development

62 Qs

Italian Articles/Plurals Practice

Italian Articles/Plurals Practice

2nd Grade - Professional Development

62 Qs

Spanish 1st 9-Weeks Exam 1

Spanish 1st 9-Weeks Exam 1

KG - University

60 Qs

QCM 1 - SF ADM

QCM 1 - SF ADM

University

62 Qs

Quiz Sistem Pengkondisian Udara (AC) Mobil

Quiz Sistem Pengkondisian Udara (AC) Mobil

University

61 Qs

Buap 1

Buap 1

University

60 Qs

Practice Cases Arrythmias/Stroke/ACS Exam 4

Practice Cases Arrythmias/Stroke/ACS Exam 4

Assessment

Quiz

Other

University

Medium

Created by

Melitza Vargas Santiago

Used 2+ times

FREE Resource

62 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

What is the mechanism of ticagrelor’s benefit in a STEMI patient that has already received ASA, oxygen, nitrates, and morphine?

Ticagrelor improves myocardial oxygen supply.

Ticagrelor opens up the infarct-related artery.

Ticagrelor reduces myocardial oxygen demand.

Ticagrelor prevents myocardial reinfarction.

2.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

Which of the following medications given during the treatment of VF or pulseless VT has no dose maximum?

3.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

A 63-year-old African American man with a PMH significant for dyslipidemia presented to the emergency department several days ago with symptoms of an acute stroke. The physician you are working with wants your recommendations on what to send this patient home on for blood pressure control. Current vitals are as follows: BP 138/88 mm Hg, HR 86 beats/min What do you recommend?

β-Blocker

Nondihydropyridine calcium channel blocker

Angiotensin-converting enzyme inhibitor plus a diuretic

No blood pressure medication. The patient’s blood pressure is at goal.

4.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

Which of the following is an appropriate fibrinolytic dosing regimen for a 78-kg person with STEMI?

Streptase 1 million units intravenously over 20 minutes

Reteplase or rPA 10 units IV bolus twice 30 minutes apart

Tenecteplase or TNK 80 mg IV bolus once

Alteplase 100 mg IV over 2 hours

5.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

What is the initial step in therapy for a stable patient presenting with monomorphic VT?

6.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

KE presents with chest pain, nausea, vomiting, and diaphoresis. He is diagnosed with an NSTEMI. Current blood pressure is 92/56 mm Hg and HR is 105 beats/min. Which of these medications should be given to this patient?

ASA EC 325 mg orally once

ASA 81 mg two tablets chewed once

NTG IV drip at 20 mcg/min

IV metoprolol 5 mg IV once

7.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

A 79-year-old man weighing 80 kg presents to your hospital emergency room with newly discovered AF with rapid ventricular response and is symptomatic with little rate control achieved after initiation of a diltiazem drip. It is decided by the attending physician to proceed with electrical cardioversion. The patient’s wife reports that he underwent a cardiac workup the day before for routine knee replacement surgery. The ECG from that workup is retrieved and shows normal sinus rhythm. What is the next appropriate step in this patient’s care?

Proceed with synchronized direct cardioversion after receiving enoxaparin 80 mg.

Anticoagulate with warfarin for 3 weeks, target INR 2.0 to 3.0, then cardioversion.

Obtain transesophageal ECHO to rule out thrombus then cardioversion.

Proceed with synchronized direct current cardioversion without anticoagulation.

Create a free account and access millions of resources

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

By signing up, you agree to our Terms of Service & Privacy Policy

Already have an account?